Human plasma was incubated with cisplatin over 24 h. Ultrafilterable platinum and platinum reactive with DDTC were determined at regular time intervals during incubation. At each time point more platinum reacted with sodium N, Nl-diethyldithiocarbamate (DDTC) than was available as ultrafilterable platinum. At 24 h 70% of total platinum (10% ultrafiltrable platinum and 60% protein-bound platinum) reacted with DDTC. This means that cisplatin bound to plasma proteins can -at least in partstill react with strong nucleophiles.
Introduction
Binding of cisplatin to plasma proteins has been studied by measuring concentrations of ultrafilterable platinum [1, 5] . Only a few papers have been published about the biological activity [4, 6] , and nothing is known about the chemical reactivity of protein-bound platinum. The present experiment has been carried out to study the chemical reactivity of protein-bound platinum with sodium diethyldithiocarbamate (DDTC). DDTC was chosen because of its strong nucleophilic properties and its possible clinical application for reduction of cisplatin-induced nephrotoxicity [3] .
Materials and methods
Cisplatin was kindly supplied by Bristol Myers (Weesp, The Netherlands). Sodium DDTC (analytical grade) was purchased from Merck (Amsterdam, The Netherlands). The PtDDTC2 complex was synthesized by the procedure of Bannister et al. [2] . Binding of cisplatin to human plasma proteins was studied in vitro by incubating 50 l.tM cisplatin in plasma at 37 ° C for 24 h. At 0, 0.5, 1, 2, 4, 6, 8 and 24 h after the start of incubation 1-ml aliquots were taken for ultrafiltration and for reaction with sodium DDTC. U1-trafiltration was performed in Amicon MPS-1 micropartion systems (Amicon, Oosterhout, The Netherlands) containing YMT membranes (cut-off 30000 daltons) at 2000 g in a bench-top centrifuge with a fixed angle rotor [7] . The first 8-min fraction was collected for the determination of ultrafilterable platinum (sol. A). DDTC-reactive platinum was determined by adding 100 ]xl 2.5.10 -2 MDDTC in waOffprint requests to: W. J. F. van der Vijgh, Academisch Ziekenhuis Vrije Universiteit, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands ter (which means a 500-fold excess with respect to platinum present in plasma) to a 1-ml aliquot of plasma, followed by incubation at 37°C for 4 h. The mixture was fractionated by a Sep Pak C-18 cartridge (Waters, EttenLeur, The Netherlands): the eluate was obtained immediately after introduction of the complete reaction mixture in plasma (Sol. B) and the eluate, after purging of the cartridge with 50 ml methanol containing the reaction product PtDDTC2. The methanol solution was evaporated under vacuum and the residue redissolved in 2 ml ethanol (Sol. C). The platinum compounds retained on the Sep Pak column were removed by digesting the packing material with 3 ml 65% HNO 3 at 170°C in a polytetrafluoroethylene (PTFE) bomb for 2 h. The remaining liquid was evaporated at 120°C under a stream of air after addition of 5 mg NaC1. The residue was dissolved in 1 ml 0.2 N HC1-0.15 M NaC1 (Sol. D). Platinum concentrations in solutions A-D were determined by atomic absorption spectrometry as described before [8] . Standard solutions of cisplatin were prepared in the same matrix as the samples.
Results and discussion
The amounts of platinum detected in the four above-mentioned solutions are summarized in Table 1 . The amounts of platinum present in solution A represent ultrafilterable platinum. The observed biphasic decrease of the platinum concentration with time corresponded with the results of previous studies [1, 2, 4, 6] . Platinum concentrations in solution B represent platinum irreversibly bound to proteins. This amount increased with time. However, if all platinum bound to plasma proteins is actually irreversibly bound then the amounts present in the solutions A and B together should total 100%. The lower values observed indicate that some of the protein-bound platinum species can be removed by the strongly nucleophile DDTC. This is in agreement with the higher platinum concentrations in solution C, representing Pt-DDTC adducts, than in solution A. Nevertheless, two peculiarities are observed: (a) the amounts present in solutions B and C together do not add up to 100%; and (b) the amounts of platinum present in solution C were expected to decrease continuously with time, but the amounts at the two latest time points were higher than the preceding values. In an attempt to find an explanation for these observations the amount of platinum retained on the column was measured at various time points. The amounts present in solution D did indeed complete the 100% platinum balance when added to the amounts 
